Company Analysis

SI-BONE, Inc. (SIBN)

Nasdaq: SIBN · Surgical & Medical Instruments & Apparatus · Santa Clara, CA · filing with the SEC since 2009
Grade6.5
◀ Past 6.7● Present 6.8▶ Future 5.8
1 est.

Who owns SI-BONE, Inc.

As filed with the SEC
Holders of 5% or more
5
Mathew P. Arens holds 18.4% of Common Stock, $0.001 par value, as its SCHEDULE 13G/A filed May 7, 2026 says.
Directors and officers
11
report now, of 24 people on the record since 2018. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Mathew P. Arens
SCHEDULE 13G/A · filed May 7, 2026 · Common Stock, $0.001 par value · 11.9% in Dec 5, 2025
18.4%
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 30, 2026 · Common Stock · 6.9% in Apr 24, 2026
8%
Cadian Capital Management, LP
SCHEDULE 13G · filed Aug 14, 2026 · Common Stock, par value $0.0001 per share
7.5%
Brown Advisory Inc
SCHEDULE 13G/A · filed Feb 13, 2026 · Common Stock · 7.6% in Apr 18, 2025
5.79%
American Century Investment Management, Inc.
SCHEDULE 13G/A · filed Feb 13, 2026 · Common Stock · 6.6% in Nov 14, 2025
5.3%
Champlain Investment Partners, LLC
SCHEDULE 13G · filed Feb 12, 2026 · Common Stock · reported falling below 5%, from 5% in Aug 12, 2025
under 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
under 5%
OrbiMed Capital LLC
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 5.1% in Aug 14, 2025
under 5%
What SIBN reports owning in othersstakes of 5% or more, and other ties

3 subsidiaries in 3 countries, from the list filed with the 10-K filed Feb 24, 2026.

Insider tradesForm 4
113sales
0purchases
40sales on a scheduled plan
7people selling
$16.7Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 9, 2025 to Nov 9, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
181920212223242526
2026 runs to Nov 9, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window7 of 32 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Francis LauraChief Executive Officer29$6.6M110$0
Dunn Jeffrey WChairman, President & CEO13$3.9M80$0
Pisetsky Michael ASVP, Ops & Adm/Chief Legal Ofr29$3.6M60$0
Maheshwari AnshulChief Op & Financial Officer30$2.0M150$0
Recupero Anthony JPresident, Commercial Ops9$500,00000$0
Davis Timothy E Jrdirector2$100,00000$0
Nishimura Mikadirector1$100,00000$0
SI Assistanton SIBN · research, not advice